Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) stock jumped 20.26% on Monday to $0.19 against a previous-day closing price of $0.16. With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.19 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.1920 whereas the lowest price it dropped to was $0.1600. The 52-week range on SNOA shows that it touched its highest point at $2.68 and its lowest point at $0.12 during that stretch. It currently has a 1-year price target of $3.12. Beta for the stock currently stands at 1.27.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SNOA was up-trending over the past week, with a rise of 22.41%, but this was down by -68.58% over a month. Three-month performance dropped to -78.22% while six-month performance fell -80.44%. The stock lost -91.00% in the past year, while it has lost -82.88% so far this year. A look at the trailing 12-month EPS for SNOA yields -1.48 with Next year EPS estimates of -0.36. For the next quarter, that number is -0.16. This implies an EPS growth rate of 29.49% for this year and 52.99% for next year.
Float and Shares Shorts:
At present, 13.68 million SNOA shares are outstanding with a float of 13.08 million shares on hand for trading. On Oct 30, 2023, short shares totaled 48580.0, which was 0.36% higher than short shares on Sep 28, 2023. In addition to Ms. Amy M. Trombly as the firm’s CEO, President & Director, Mr. Jerome J. Dvonch serves as its Interim Chief Financial Officer.
Institutional Ownership:
Through their ownership of 2.97% of SNOA’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 8.59% of SNOA, in contrast to 1.94% held by mutual funds. Shares owned by individuals account for 0.78%. As the largest shareholder in SNOA with 0.74% of the stake, Two Sigma Securities LLC holds 38,522 shares worth 38,522. A second-largest stockholder of SNOA, Geode Capital Management LLC, holds 35,780 shares, controlling over 0.69% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in SNOA, holding 24,315 shares or 0.47% stake. With a 0.56% stake in SNOA, the Fidelity Extended Market Index Fu is the largest stakeholder. A total of 29,083 shares are owned by the mutual fund manager. The Fidelity Nasdaq Composite Index F, which owns about 0.10% of SNOA stock, is the second-largest Mutual Fund holder. It holds 4,975 shares valued at 811.0. Vanguard Extended Market Index Fu holds 0.07% of the stake in SNOA, owning 3,818 shares worth 622.0.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SNOA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SNOA analysts setting a high price target of $3.25 and a low target of $3.00, the average target price over the next 12 months is $3.13. Based on these targets, SNOA could surge 1610.53% to reach the target high and rise by 1478.95% to reach the target low. Reaching the average price target will result in a growth of 1547.37% from current levels.
Summary of Insider Activity:
Insiders traded SNOA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 200,000 while 0 shares were sold.
